| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 02/05/2003 | CN1394846A Alpha-substituted benzene acetic acid its preparation and farm pesticide containing said compound |
| 02/04/2003 | US6515175 Mono-and polyamides of perfluoroalkyl-substituted unsaturated acids |
| 02/04/2003 | US6515025 Use of ethynyl alanine amino diol compounds to inhibit enzymatic conversion of angiotensinogen to angiotensin I |
| 02/04/2003 | US6515011 Anticoagulants |
| 01/31/2003 | WO2002012169A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/31/2003 | CA2417880A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/30/2003 | US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family |
| 01/30/2003 | US20030022935 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents |
| 01/29/2003 | EP1278736A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/28/2003 | US6511988 Prevention binding of transcription factor tozinc finger binding compounds |
| 01/23/2003 | WO2003006628A2 Nad synthetase inhibitors and uses thereof |
| 01/23/2003 | WO2003006489A2 Prodrugs of excitatory amino acids |
| 01/23/2003 | WO2003006453A1 Aminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2003006421A1 Method for purifying n2-(1(s)-ethoxycarbonyl-3- phenylpropyl)-n6-trifluoroacetyl-l-lysine |
| 01/23/2003 | WO2003006021A1 Alpha-hydroxyamide statine derivatives for the treatment of alzh eimer's disease |
| 01/23/2003 | WO2003006013A1 Diaminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2003005971A2 Tetracycline compounds having target therapeutic activities |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018016 Cell adhesion inhibitors |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | CA2453451A1 Aminediols for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453447A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453444A1 Diaminediols for the treatment of alzheimer's disease |
| 01/23/2003 | CA2422349A1 Process for purifying n2-(1(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine |
| 01/22/2003 | EP1276714A2 Cyclic carboxylic acids as integrin antagonists |
| 01/22/2003 | EP1276713A1 Inhibition of angiogenesis and tumor growth |
| 01/22/2003 | EP1276711A2 Synthesis of midodrine hci from a novel intermediate 1-(2',5'-dimethoxyphenyl)-2-azidoethanone |
| 01/22/2003 | EP1071660B1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/22/2003 | CN1392137A New cyclic alpha-amino-gamma hydroxy amide compound, its preparing method and medicinal composition containing said compound |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/22/2003 | CN1099407C Novel amino acid derivatives with improved multi-drug resistance activity |
| 01/22/2003 | CN1099406C Alkoxy acetic acid derivatives |
| 01/21/2003 | US6509463 Isocyanoalkylcarbonic acid derivatives, the reaction thereof in isocyanide multicomponent reactions to form sec-amido-alkylcarbonic acid derivatives, and those sec-amidoalkyl-carbonic acid derivatives |
| 01/21/2003 | US6509378 Acetamidobenzamide compounds for neurodegenerative disorders |
| 01/16/2003 | WO2003003987A2 Solid phase synthesis of arylretinamides |
| 01/16/2003 | WO2001062705A3 Aminoalcohol derivatives |
| 01/16/2003 | US20030013881 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013719 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/16/2003 | US20030013704 Adamantane derivatives |
| 01/16/2003 | US20030013677 Anticancer agents |
| 01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
| 01/16/2003 | US20030012817 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 01/15/2003 | EP1275386A1 Solid dispersion with improved absorbability |
| 01/15/2003 | CN1391577A Pharmaceutical compositions comprising metal complexes |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/14/2003 | US6506938 Process for the purifying of iopamidol |
| 01/14/2003 | US6506928 Derivative in which fullerene is linked to at least one dendron having at least one protic group which imparts water solubility |
| 01/14/2003 | US6506798 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors |
| 01/14/2003 | US6506740 Compounds that can be substituted at the 7, 8, and/or 9 positions and methods for preparing the 4- dedimethylamino tetracycline compounds. Other tetracycline compounds are the 4-dedimethylaminotetracycline derivatives with an oxime |
| 01/14/2003 | US6506733 Compounds and compositions as protease inhibitors |
| 01/14/2003 | CA2068752C Alkanoyl l-carnitine amides with aminoacids and pharmaceutical compositions containing same for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the processes of learning and memory and for the treatment of coma |
| 01/14/2003 | CA2023089C Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia |
| 01/09/2003 | WO2003002545A1 Peptoid compounds |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2002048092A3 Compounds for altering mitochondrial function and cellular responses |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008900 Compounds and compositions for delivering active agents |
| 01/09/2003 | US20030008881 Substituted phenylcyclohexanecarboxamides and their use |
| 01/09/2003 | US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 01/08/2003 | EP1272459A1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 01/08/2003 | EP1272173A1 Methods for inhibiting angiogenesis and tumor growth |
| 01/08/2003 | EP1095011A4 Novel fluorescent lanthanide chelates |
| 01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/08/2003 | CN1098278C Cinnamic acid derivative |
| 01/07/2003 | WO2002008171A2 Method for separating ammoniac |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | CA2415245A1 Method for separating ammoniac |
| 01/07/2003 | CA2192481C Drug salts |
| 01/03/2003 | WO2003000698A1 β-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING |
| 01/02/2003 | US20030004367 Such as (Z)-4-(tert-butylamino)-4-oxo-2-butenoic acid; protective coatings for use as two-part liquid pavement markings |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | US20030004138 Hypoglycemic agents; antidiabetic agents; dietetics |
| 01/02/2003 | EP1270562A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof |
| 01/02/2003 | EP1270547A1 Novel phenylalanine derivative |
| 01/02/2003 | EP1268414A1 Ceramide derivatives and method of use |
| 01/02/2003 | EP1268402A2 Process for preparing 6-aminocaproamide |
| 01/02/2003 | EP1268396A1 Diphenyl ether compounds useful in therapy |
| 01/01/2003 | CN1388804A Amino acid-N-carboxy anhydrides having substitent at nitrogen |
| 01/01/2003 | CN1388115A Carbon nuclein labelled lidocaine as liver reserve function testing agent |
| 12/31/2002 | US6500825 Substituted 2-aminoacetamides and the use thereof |
| 12/31/2002 | US6500812 Gastrointestinal disorders; antiinflammatory agents |
| 12/31/2002 | US6500213 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives |
| 12/27/2002 | WO2002070473A3 Carboxamide derivatives as therapeutic agents |
| 12/27/2002 | WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 12/26/2002 | US20020198220 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
| 12/24/2002 | US6498274 Amide derivatives for the treatment of diseases mediated by cytokines |
| 12/24/2002 | US6498273 For imaging organs or structures including blood vessels, a thrombus within a vessel, heart, brain, kidney, liver, lungs, spleen, etc., meidcal diagnosis |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 12/19/2002 | WO2002100820A1 Substituted aminoalcohols useful in treatment of alzheimer's disease |
| 12/19/2002 | WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/19/2002 | WO2002100341A2 Compounds for the treatment of metabolic disorders |
| 12/19/2002 | WO2002100172A1 Administration of agents via the pept-2 transporter |
| 12/19/2002 | US20020193635 Intermediate for preparing midodrine |
| 12/19/2002 | US20020193614 Treatment of cardiovascular disorders |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |